Cytotrophoblasts are specialized epithelial cells of the human placenta that differentiate to acquire tumor-like properties that allow them to invade the uterus. Concurrently, they develop endothelial-like characteristics. This transformation allows cytotrophoblasts to replace the maternal cells that line uterine vessels, thereby diverting maternal blood to the placenta. Previously, we showed that invading cytotrophoblasts secrete VEGF-C and PlGF, factors that regulate their acquisition of an endothelial-like phenotype. Here, we examined the cells' expression of angiopoietin ligands and their Tie receptors. The data show that cytotrophoblasts predominantly expressed Ang2. We also studied the paracrine functions of Ang2 and the VEGFs by culturing uterine microvascular endothelial cells in cytotrophoblast-conditioned medium, which supported their growth. Removal of VEGF-C, PlGF, and/or Ang2 from the medium caused a marked reduction in cell number due to massive apoptosis. We also assayed the angiogenic potential of cytotrophoblast-derived factors in the chick chorioallantoic membrane assay. The results showed that they stimulated angiogenesis to a level comparable to that of basic FGF. These data suggest that invasive human cytotrophoblasts use an unusual repertoire of factors to influence the angiogenic state of maternal blood vessels and that this cross talk plays an important part in the endovascular component of uterine invasion.
Introduction
During development, the human placenta performs a subset of the functions accomplished after birth by organs of the body that carry out exchange and transport processes, e.g., the kidneys, lungs, and digestive system. Like other organs, the placenta develops its own intrinsic vasculature that in this case carries blood to and from the fetus. However, placentation entails a higher order of complexity, because survival of the conceptus requires this extraembryonic structure to form elaborate connections with uterine vessels, a novel form of vasculogenesis. This process allows the placenta to tap a supply of maternal blood, a crucial hurdle for establishing and maintaining pregnancy. To accomplish this feat, the placenta's specialized epithelial cells, termed cytotrophoblasts, acquire tumor-like properties that allow them to adhere to the uterus, which they subsequently invade.
Viewed from a developmental perspective, this unusual process is the result of cytotrophoblast differentiation along the invasive pathway. The progenitor population of embryonic/fetal cytotrophoblasts, including a stem cell reservoir, forms a polarized epithelium that is attached to the basement membrane surrounding the stromal cores of chorionic villi. As differentiation/invasion begins, clusters of cells in selected regions leave this basement membrane to form columns of unpolarized cells that attach to and then penetrate the uterine wall. The ends of the columns terminate within the superficial endometrium, where they give rise to invasive cytotrophoblasts. During interstitial invasion, a subset of these cells, either individually or in small clusters, commingle with resident decidual, myometrial, and immune cells. During endovascular invasion, masses of cytotrophoblasts migrate into uterine vessels before the lumina eventually recanalize sometime near the end of the first trimester of pregnancy. Together the two components of cytotrophoblast invasion anchor the placenta to the uterus and permit a steady increase in the supply of maternal blood to the growing fetus.
Work from our group and others suggests that this novel differentiation program is controlled through the coordinated actions of numerous interrelated factors, such as vascular-endothelial cadherin, several integrins, and Ig superfamily members, that allow the cells to mimic the surface of vascular cells (Damsky and Fisher, 1998) . Matrix metalloproteinase-9 also has an important role in invasion (Librach et al., 1991) and may play novel roles in regulating the bioavailability of morphogens and growth factors in the extracellular milieu (Hattori et al., 2002) . Upstream regulators include physiological parameters such as oxygen tension, which triggers either stem cell proliferation in hypoxia or differentiation/invasion as the cells encounter higher oxygen levels inside the uterine wall (Genbacev et al., 1996 (Genbacev et al., , 1997 . As in other cells, fate is specified by transcriptional networks. Those known to play a role in cytotrophoblast differentiation include factors whose abundance is regulated by oxygen tension, e.g., the helix-loop-helix factor inhibitor of DNA binding protein 2 (Janatpour et al., 2000) , and a mammalian homologue of Drosophila achaete/scute complex genes (Janatpour et al., 1999) that is required for maintenance of the murine trophoblast stem cell population (Guillemot et al., 1994) . Unexpectedly, a homologue of the Drosophila neuronal fate gene, glial cells missing-1 (gcm-1), also plays an important role in the early stages of trophoblast differentiation (Janatpour et al., 1999; Anson-Cartwright et al., 2000) .
These regulators act in concert with specific growth factors. Given the unusual vascular phenotype that invasive cytotrophoblasts adopt and the unique connections they form with maternal vessels, we have been particularly interested in the cells' repertoire of substances that influence vasculogenesis and angiogenesis. We have shown that cytotrophoblast differentiation and invasion during the first and second trimesters of pregnancy are associated with downregulation of vascular endothelial growth factor (VEGF) receptor (VEGFR)-2 (Zhou et al., 2002) . Invasive cytotrophoblasts in early gestation expressed VEGF-A, VEGF-C, placental growth factor (PlGF), VEGFR-1, and VEGFR-3 and, at term, VEGF-A, PlGF, and VEGFR-1. In vitro, the cells incorporated VEGF-A into the surrounding extracellular matrix, whereas PlGF and VEGF-C were secreted. We also found that cytotrophoblasts respond to the VEGF ligands they produce. Blocking ligand binding significantly decreased their expression of integrin ␣1, an adhesion molecule highly expressed by endovascular cytotrophoblasts, and increased apoptosis. Our results showed that VEGF family members regulate cytotrophoblast differentiation, survival, and, consequently, invasion.
The focus of our current studies is the paracrine actions of angiogenic and vasculogenic factors secreted by cytotrophoblasts. We hypothesized that these actions play an important role in endovascular invasion and in the subsequent formation of hybrid maternal-fetal vessels within the uterine wall that carry blood to and from the placenta. First, we investigated cytotrophoblast expression of Ang/Tie family members that, along with VEGFs, play important roles in formation of the vasculature (Saaristo et al., 2000; Thurston, 2002; Gale et al., 2002) . To assess function, we cultured isolated endothelial cells in cytotrophoblast-conditioned medium alone or in medium from which the VEGFs and/or Ang2 had been removed. We also used the chick chorioallantoic membrane assay to quantify the net angiogenic effects of early-gestation cytotrophoblast-conditioned medium with or without VEGF-C, PlGF, and/or Ang2.
Materials and methods

Tissue collection
Placentas were obtained immediately after elective terminations of pregnancy (6-22 weeks) or from normal term deliveries (34 -40 weeks), washed thoroughly in phosphatebuffered saline (PBS) containing antibiotics, and placed on ice. For in situ hybridization, specimens from the maternalfetal interface were immediately fixed in 10% formalin/PBS at room temperature.
Placental cell isolation and culture
Cytotrophoblasts were isolated either from pools of firstor second-trimester placentas or from individual third-trimester placentas, as previously described (Kliman et al., 1986; Librach et al., 1991) . Briefly, placentas were subjected to a series of enzymatic digestions that detached cytotrophoblasts from the underlying stromal cores of the chorionic villi. Detached cytotrophoblasts were isolated on a Percoll gradient. The cells were cultured for up to 72 h on Matrigel-coated substrates (Collaborative Biomedical Products, Bedford, MA) in serum-free Dulbecco's modified Eagle's medium (DMEM) containing 4.5 g/liter of glucose (Sigma Chemical Co., St. Louis, MO), supplemented with 2% Nutridoma (Boehringer Mannheim Biochemicals, Indianapolis, IN), 1% penicillin/streptomycin, 1% sodium pyruvate, 1% Hepes, and 1% gentamcin (UCSF Cell Culture Facility).
Placental fibroblasts were isolated from the denuded stromal cores of chorionic villi as previously described (Fisher et al., 1989) . The cells were maintained in DMEM H-21 containing 10% fetal bovine serum, 5% glutamine, 1% penicillin/streptomycin, and 1% gentamcin. The JAR, JEG, and BeWo human choriocarcinoma cell lines were maintained as previously described (Fisher et al., 1989) .
Northern blot hybridization
Control samples of total RNA extracted from human heart were purchased from Clontech (Palo Alto, CA). All other RNA samples were prepared in the laboratory. Some samples came from specific tissue compartments, such as cell columns of anchoring villi. Others were from isolated cells. The latter included purified first-(I), second-(II), and third-(III)trimester cytotrophoblasts from which total RNA was obtained either immediately after isolation or after culture for up to 72 h. Fibroblasts isolated from first-trimester placentas were used only after the third passage to ensure the absence of other cell types. RNA was also obtained from the human choriocarcinoma cell lines JEG, JAR, and BeWo.
Total RNA was isolated according to published methods (Chomczynski and Sacchi, 1987) , and subjected to Northern blot hybridization as previously described (McMaster et al., 1995) . Before transfer, gels were stained with acridine orange to ensure the integrity of the RNA samples and equal loading.
Plasmids for Ang1, Ang2, Tie1, and Tie2 were the kind gift of Regeneron Corporation, Tarrytown, NY. Probe sizes and sequences were as follows: angiopoietin-1 (570 bp) including 70 bp of the 5Ј untranslated region and 500 bp of the region up to amino acid 166; angiopoietin-2 (640 bp) including 360 bp of the 5Ј untranslated region and 280 bp of the region up to amino acid 99; Tiel (562 bp) including the ectodomain region (amino acids 162-349); and Tie 2 (508 bp) including the ectodomain region (amino acids 70 -239). The corresponding sense probes were synthesized and used as controls.
Probes with a specific activity of 2 ϫ 10 9 dpm/g were generated by random priming of the purified fragments using [ 32 P]dCTP (Amersham Life Sciences-USB, Arlington Heights, IL) and the Klenow fragment of DNA polymerase I according to standard methods (Tabor et al., 1993) . Hybridization and autoradiography were carried out as previously described (McMaster et al., 1995) .
Immunolocalization
Isolated cytotrophoblasts were processed for double indirect immunolocalization by using methods that are standard in our laboratory (Fisher et al., 1989; Damsky et al., 1992) . Briefly, after 12 h of culture, cells were fixed in cold acetone for 5 min, then incubated in PBS (4°C) for another 5 min before they were exposed to a mixture of primary antibodies. The rat anti-human cytokeratin monoclonal antibody 7D3, produced in the Fisher laboratory, was used at a dilution of 1:50 for immunolocalization. Goat anti-angiopoietin-2 (R&D Systems, Minneapolis, MN) was used at a dilution of 1:100. After 1 h, the cells were rinsed in PBS (4°C) and incubated with the appropriate species-specific secondary antibodies (Jackson ImmunoResearch Labs, Inc., West Grove, PA) conjugated to rhodamine or fluorescein. Control cells were exposed to only the secondary antibody. After washing an additional three times in PBS (15 min total), the coverslips were mounted on slides and examined with a Zeiss Axiophot epifluorescence microscope (Thornwood, NY). Control cells were incubated in secondary antibody alone.
In situ hybridization
In situ hybridization was carried out by using methods we previously published (Drake et al., 2001) . Labeled probes were produced from the Ang and Tie plasmids described above, and after linearization they were used as templates for the synthesis of 35 S-cRNA probes using T3 or T7 RNA polymerases.
Ligand depletion of cytotrophoblast-conditioned medium
Conditioned medium was collected from isolated cytotrophoblasts after 40 h of culture. The medium was centrifuged before the samples were frozen at Ϫ80°C prior to use. Fusion proteins, consisting of the ligand-binding domains of VEGFR-1, VEGFR-3, or Tie2 fused to the Fc portion of IgG, and a control CD6-Fc protein were purchased from R&D Systems.
Preliminary experiments were conducted to determine, by immunoblotting (Zhou et al., 2002) , the amount of each fusion protein that was required to remove the relevant ligand, and this protein concentration was subsequently used. Briefly, at the start of each experiment, 1 ml of conditioned medium was placed in a microfuge tube. VEGFR-1-Fc (300 ng/ml), VEGFR-3-Fc (4 g/ml), or Tie2-Fc (5 g/ml) fusion proteins were added separately or together. The CD6-Fc protein (3 g/ml) was added to the control samples. Ligand binding was accomplished by incubation, with rotation, for 2 h at 4°C. Afterwards, 100 l of packed protein A-Sepharose CL-4B beads (Zymed Laboratories, So. San Francisco, CA) was added, and the samples were incubated/rotated for 2 h at 4°C. Receptor-ligand complexes were removed by repeated centrifugation. The supernatants were transferred to new microfuge tubes and stored at Ϫ80°C before use.
To ensure that the medium was depleted of the relevant ligands, samples containing equal amounts of total protein were mixed with loading buffer and separated by 15% sodium dodecyl sulfate-polyacrylamide gel electrophoresis under reducing conditions. After the proteins were transferred to nitrocellulose, the membranes were incubated with the following primary goat antibodies diluted 1:1000 in PBS containing 5% nonfat dried milk and 0.1% Tween 20: anti-P1GF (Santa Cruz Biotechnology, Santa Cruz, CA); anti-VEGF-C (R&D Systems); and anti-Ang2 (R&D Systems). Antibody binding was detected with peroxidase-conjugated donkey anti-goat IgG (Jackson ImmunoResearch Labs). Im-mune complexes were visualized by using an ECL kit and Hyperfilm (Amersham). Only samples that were Ͼ90% depleted of ligand were used in the in vitro and in vivo assays.
Uterine microvascular endothelial cell (UtMVEC) proliferation and apoptosis assays
Human UtMVECs were obtained from BioWhittaker Inc. (Baltimore, MD). Routinely, the cells were cultured in EGM-2-MV medium (BioWhittaker Inc.) and used before the 10th passage. At the start of each experiment, UtMVECs were resuspended in control or experimental samples of cytotrophoblast-conditioned medium containing 8% fetal bovine serum and plated at a density of 4 ϫ 10 4 /400 l in 8-well chamber slides. After incubation for 12 h, the cells were quickly washed twice in PBS at room temperature, and the nuclei were visualized by staining with DAPI (4Ј, 6Јdiamidino-2-phenylindole) as previously described (Genbacev et al., 1997) . Then, the chambers were removed, and coverslips were mounted on top of the slides before the total cell number was counted by using a Zeiss Axiophot epifluorescence microscope. Each condition was tested in triplicate. The entire assay was done four times. Data are expressed as percentage of controls. The statistical significance of the results was analyzed by ANOVA.
In preliminary experiments, apoptosis was assessed by using the terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick-end labeling (TUNEL) method. Briefly, UtMVECs were cultured for 12 h in experimental or control samples of conditioned medium as described above. Then, the cells were fixed in 3% paraformaldehyde for 30 min, washed twice with PBS, and permeabilized with 0.1% Triton X-100 in 0.1% sodium citrate for 4 min on ice. Finally, the UtMVECs were incubated in the TUNEL reaction mixture (Boehringer Mannheim Biochemicals) and DAPI for 1 h at 37°C. The percentage of TUNEL-reactive cells was determined by using a Zeiss Axiophot epifluorescence microscope. The results showed TUNEL reactivity and obvious nuclear fragmentation. Thereafter, apoptosis was scored by visualizing nuclear morphology after DAPI staining. Each condition was tested in triplicate. The entire assay was done three times. The statistical significance of the results was analyzed by ANOVA.
Chick embryo chorioallantoic membrane (CAM) assay
A modified version of the assay described by Brooks et al. (1999) was employed. Briefly, fertilized White Leghorn chicken eggs (California Golden Egg Inc., Petaluma, CA) were incubated for 10 days at 37°C in 94% humidity to allow development of embryos with suitable CAMs. A Fig. 1 . Diagram of the histological organization of the human maternal-fetal interface at midgestation. Cytotrophoblasts, which are specialized (fetal) epithelial cells of the placenta, differentiate and invade the uterine wall (interstitial invasion), where they also breach maternal blood vessels (endovascular invasion). The basic structural unit of the placenta is the chorionic villus, composed of a stromal core with blood vessels, surrounded by a basement membrane and overlain by cytotrophoblasts. As part of their differentiation program, these cells detach from the basement membrane and adopt one of two lineage fates. They either fuse to form the multinuclear syncytiotrophoblasts that cover floating villi (FV) or join a column of mononuclear extravillous cytotrophoblasts at the tips of anchoring villi (AV). The syncytial covering of floating villi mediates the nutrient, gas and waste exchange between fetal and maternal blood. The anchoring villi, through the attachment of cytotrophoblast columns, establish physical connections between the fetus and the mother. Invasive cytotrophoblasts penetrate the uterine wall up to the first third of the myometrium. A portion of the extravillous cytotrophoblasts home to uterine spiral arterioles and remodel these vessels by replacing the endothelial lining and intercalating within the muscular walls. To a lesser extent, they also remodel uterine veins. Diagram modified from Hoang et al. (2001). small hole was made with a drill (Dremel-Emerson Electric, Racine, WI) directly over the air sac at the broad end of the egg, which was candled to determine the drilling site of a second hole directly over the CAM. Gentle pressure was applied with forceps through the second hole to drop the CAM. Then, a grinding wheel (Dremel-Emerson Electric) was used to cut a 1 ϫ 1-cm 2 window in the eggshell over the dropped CAM. Ten microliters of a 3-mg/ml solution of cortisone acetate was applied to a sterilized disk of Whatman type I filter paper, 6 mm in diameter, which was allowed to air dry in a tissue culture hood before it was placed through the eggshell window onto the center of the CAM. Then, 80 l of control or experimental medium, the maximum absorbable volume, was loaded onto each disk.
The window was sealed with sterile transparent tape, and the eggs were incubated at 37°C. After 48 h, the CAM was dissected from the disk. The entire area that was directly exposed to the disk was imaged by using a Zeiss M2 Mat dissection microscope and photographed with a SPOT digital camera (Stemi 2000C; Diagnostic Instruments, Inc., Sterling Heights, MI). In each experiment, the angiogenic response induced by samples of control and experimental conditioned medium was evaluated by using six to eight eggs. The entire assay was conducted seven times. The angiogenic response was quantified by counting the total number of capillaries that formed beneath the disk. The mean capillary density was calculated for each sample and expressed as a percentage of the control. VEGF-A (R&D Fig. 2 . In vitro, human placental cytotrophoblasts primarily express Ang2 at the mRNA and protein levels. Cytotrophoblasts were isolated from first-(I), second-(II), and third-(III) trimester human placentas. mRNA was prepared from cells immediately after they were isolated (0 h) or after they were plated on Matrigel for up to 72 h, during which time they fully differentiated and assumed the phenotype of cytotrophoblasts that invade the uterus in vivo. (A) Neither cultured cytotrophoblasts nor the JAR choriocarcinoma cell line expressed Ang1 mRNA. In contrast, an mRNA sample from a fibroblast line established from first-trimester human placentas contained a band corresponding to an Ang1 mRNA of the expected size. (B) Cultured cytotrophoblasts expressed Ang2 mRNA during all stages of differentiation; ϳ2.1and 3-kb mRNAs that encode the same protein were detected. The same two transcripts were detected in samples isolated from nascent cell columns that were dissected from anchoring villi. Choriocarcinoma cells (JEG, JAR, and BeWo), placental fibroblasts, and heart samples contained the 2.1-kb mRNA. (C) Cytotrophoblasts that were cultured overnight were analyzed by double indirect immunolocalization. (a) The cells stained for cytokeratin (CK), a unique feature that distinguishes them from other types of placental cells, including fibroblasts and endothelia. (b) The cells also stained with an antibody that specifically reacts with Ang2. Systems) dissolved in serum-free medium at a concentration of 5 ng/ml was used as a positive control. The statistical significance of the data was analyzed by ANOVA.
Results
First, we investigated cytotrophoblast expression of Tie receptors and their angiopoietin ligands during human cy-totrophoblast differentiation/invasion in vitro and in situ. Northern blot hybridization failed to detect expression of either the Tie1 or the Tie2 receptor (data not shown). In contrast, control human microvascular endothelial cells expressed mRNA encoding both receptors. With regard to ligands, Ang1 mRNA expression was detected in human first-trimester placental fibroblasts, most likely a reflection of the angiogenic environment of the stromal cores of cho- Fig. 3 . In situ hybridization shows that syncytiotrophoblasts and cytotrophoblasts express Ang2 mRNA in vivo. Sections of anchoring villi and the portion of the uterine wall to which they attached were hybridized to anti-sense probes to detect Ang1 and Ang2 mRNA expression. No specific Ang1 signals were observed in association with any of the trophoblast populations (data not shown). In contrast, the hybridization pattern of the Ang2 anti-sense probe suggested that the corresponding mRNA was strongly expressed in both the syncytiotrophoblast (STB) and cytotrophoblast (CTB) populations of floating villi (data not shown) and anchoring villi (A and B) . In contrast, cells in the cytotrophoblast cell column (CC) gave no signal. (C) The control Ang2 sense probe did not give specific hybridization signals. (D and E) As cytotrophoblasts left the columns and invaded beyond the surface of the uterine wall, the cells upregulated Ang2 mRNA expression. (F and G) Cytotrophoblasts anchored to the walls of maternal blood vessels also showed strong hybridization to the anti-sense Ang2 probe, while cytotrophoblasts in the lumina of these vessels did not. rionic villi, where the intrinsic vasculature of the placenta develops (Fig. 1) . No hybridization signal was detected in first-trimester, second-trimester, or term cytotrophoblasts ( Fig. 2A) , either immediately after their isolation (0 h) or after they had differentiated in vitro for 36 h, during which time they assume a vascular phenotype. Likewise, we failed to detect Ang1 expression by the JAR choriocarcinoma (human malignant trophoblast) cell line ( Fig. 2A) .
In contrast, cytotrophoblast expression of Ang2 mRNA was detected during all three gestational periods studied and at all stages of differentiation in vitro (0 -36 or 0 -72 h of culture). The cDNA probe hybridized to a band of ϳ2.1 kb, the only mRNA found in samples isolated from placental fibroblasts, the choriocarcinoma cell lines (JEG, JAR, and Be Wo), and heart (Fig. 2B) . The same probe hybridized to bands of ϳ2.1 and ϳ3 kb in nearly all the RNA samples isolated from cell columns dissected from placental villi (see Fig. 1 ) and in cytotrophoblasts cultured for up to 72 h. Fig. 4 . PlGF, VEGF-C, and Ang2 in cytotrophoblast-conditioned medium support the growth of UtMVECs in vitro. Cells cultured in cytotrophoblastconditioned medium (CTB CM) grew at the same rate as when the cells were cultured in medium specially formulated to support their propagation (EGM-2-MV; data not shown). (A) Treatment of the medium with an irrelevant fusion protein, CD6-Fc, did not change growth rate. In contrast, treatment of the medium with VEGFR-1 (VR1-Fc), which removes PlGF, resulted in an ϳ60% decrease in the number of endothelial cells, as did treatment with fusion proteins that removed VEGF-C (VR3-Fc) or Ang2 (Tie2-Fc). Removal of Ang2, VEGF-C, and PlGF resulted in a 95% reduction in attached endothelial cells as compared with the control wells. (B) The reduction in the number of endothelial cells in cultures grown in cytotrophoblast-conditioned medium that was depleted of angiogenic factors was directly attributable to apoptosis. Bars show the standard deviation of the mean values. The significance of the data from four separate experiments was determined by ANOVA.
Both mRNAs encode the same Ang2 protein (Dr. Hao Zhou, Regeneron Corp.; personal communication) . In general, no obvious pattern of Ang2 regulation was observed during differentiation of cells isolated from first-trimester or term placentas. In contrast, cytotrophoblasts isolated from second-trimester placentas consistently exhibited an upregulation of Ang2 mRNA expression during the early stages of differentiation in vitro. This observation is in accord with our published data showing that cytotrophoblast pseudovasculogenesis peaks during this period (Fig. 2B ) (Zhou et al., 1997a) . Finally, we assayed the cells' expression of Ang2 at the protein level (Fig. 2C) . Isolated cytotrophoblasts that were cultured for 12 h stained brightly with an antibody that specifically reacts with this ligand, showing that the cells translated the Ang2 mRNA we detected into protein.
To determine whether the expression patterns of Tie receptors and their Ang ligands were the same in vitro and in vivo, we performed in situ hybridization on tissue sections from the maternal-fetal interface that contain cytotrophoblasts in all stages of differentiation (Fig. 1) . Consistent with the Northern blot hybridization experiments, we failed to detect Tie1, Tie2, or Ang1 mRNA expression among any of the trophoblast populations (data not shown). In contrast, these cells expressed Ang2 mRNA (Fig. 3) . Syncytiotrophoblasts, which cover the surfaces of chorionic villi and are in direct contact with maternal blood, gave a strong signal, as did the underlying layer of progenitor cytotrophoblasts ( Fig. 3A and B) . No signal was detected when an Ang2 sense probe was hybridized to an adjacent tissue section (Fig. 3C) . We failed to detect Ang2 mRNA expression in the proximal regions of cytotrophoblast columns that attach the placenta to the uterus (Fig. 3B and E) . However, strong Ang2 signals were once again observed in association with cytotrophoblasts that invaded beyond the surface of the uterine wall (Fig. 3E) . Likewise, cytotrophoblasts that lined maternal vessels expressed Ang2 mRNA, while those that occupied the lumina did not (Fig. 3G) .
Next, we assessed in vitro and in vivo the paracrine actions of the vasculogenic/angiogenic substances that cytotrophoblasts secrete, principally Ang2, PlGF and VEGF-C. First, we examined the effects of these factors, both individually and in combination, on UtMVECs in vitro (Fig. 4A) . Cytotrophoblast-conditioned medium promoted the growth of these cells at a rate that was comparable to their growth rate in their usual medium. Treating the medium with an irrelevant fusion protein (CD6-Fc) did not change the rate of endothelial cell mitosis or the appearance of the cells. However, treatment of the medium with VEGFR-1 [1-3]-Fc, which removes PlGF, resulted in an ϳ60% decrease in the number of endothelial cells, as did treatment with fusion proteins that removed VEGF-C (VEGFR-3 [1-3]-Fc) or Ang2 (Tie2-Fc). Many of the remaining cells had pyknotic nuclei and a shriveled appearance. Removal of Ang2, VEGF-C, and PlGF resulted in a 95% reduction in attached endothelial cells as compared with the control. Morphological changes in the remaining cells were exacerbated.
The morphology of the endothelial cells suggested that apoptosis was playing a large role in reducing the number of endothelial cells in cultures that were maintained in cytotrophoblast-conditioned medium depleted of angiogenic factors. As shown in Fig. 4B , no apoptosis was observed when the cells were cultured in conditioned medium treated with a control fusion protein (CD6-Fc). In contrast, many cells exhibited TUNEL reactivity and nuclear fragmentation, indicative of apoptosis, when PlGF, VEGF-C, or Ang2 was removed. This effect was exacerbated when cytotrophoblast-conditioned medium was depleted of all three factors.
Finally, we assessed the angiogenic effects of factors in cytotrophoblast-conditioned medium in the chick chorioallantoic membrane assay. The membranes were photographed after application of the various conditioned medium samples (Fig. 5A) , and the number of new capillary sprouts was counted (Fig. 5B) . The medium was assayed without treatment ( Fig. 5A[a] ) or after treatment with a control CD6-Fc protein ( Fig. 5A[b] ). In both cases, a robust angiogenic response was detected that was comparable to the response induced by adding either basic FGF (data not shown) or recombinant VEGF to the medium (Fig. 5A[c] ). Removal of PlGF ( Fig. 5A[d] ), VEGF-C ( Fig. 5A[e] ), or Ang2 (Fig. 5A[f] ) diminished this effect by approximately 70 -80%. However, depletion of all three factors produced no further decrease in the angiogenic capacity of cytotrophoblast-conditioned medium ( Fig. 5A[g] ), suggesting that compensatory factors have partial effects in this in vivo model.
Discussion
The results of these experiments support the important concept that, during early human pregnancy, cytotrophoblasts produce factors that act in a paracrine manner to influence the angiogenic state of uterine vessels. We previously studied the autocrine actions of VEGF family ligands (Zhou et al., 2002) , including the promotion of cytotrophoblast differentiation/invasion and survival. Here, we show that cytotrophoblasts and syncytiotrophoblasts in floating villi and cytotrophoblasts that invade beyond the uterine surface, where they occupy maternal vessels, synthesize Ang2 but not Ang1, Tie1, or Tie2. The cells' lack of receptor expression suggests that Ang2 has paracrine rather than autocrine actions.
These findings are in general agreement with the results of some investigators (Goldman-Wohl et al., 2000) but differ from the reports of those who also detected trophoblast Ang1 expression (Dunk et al., 2000; Zhang et al., 2001) . Our results were bolstered by additional data showing that purified cytotrophoblasts express only Ang2 mRNA in vitro. Knowing the identity of the major vasculogenic substances secreted by cytotrophoblasts allowed us to assess their functions. All three ligands contributed to the survival of purified UtMVECs in culture, an effect that was additive. Likewise, all three factors promoted a strong angiogenic response in the chick chorioallantoic membrane assay, although the effects were not additive, suggesting functional redundancy. Together, these findings give additional mechanistic insights into the highly unusual process that enables trophoblasts to invade and occupy maternal blood vessels, an essential feature of hemochorial placentation. Our findings also suggest that, in humans, PlGF, VEGF-C, and Ang2 are essential to this process.
The actions of Ang2 are complex (Veikkola and Alitalo, 2002) . For example, Ang2 expression is characteristic of neovascular endothelium , but high Ang2 expression is also observed during regression of the corpus luteum (Maisonpierre et al., 1997) . These apparently contradictory findings can be explained by considering Ang2 actions in the context of VEGF levels. When levels of both ligands are high, Ang2 promotes vessel destabilization, favoring angiogenesis. In the absence of VEGF, Ang2 promotes endothelial apoptosis . When we assessed the effects on isolated endothelial cells of trophoblast-derived PlGF, VEGF-C, and Ang2, alone and in combination, our results were consistent with this interpretation. Recent gene knockout experiments in mice provide further insights into the unusual nature of Ang2 actions (Gale et al., 2002) . The homozygous null animals (Ang2 Ϫ/Ϫ ) do not display defects in angiogenesis before birth, but postnatal angiogenesis is disrupted. For example, Ang2 knockout mice show impaired retinal blood vessel development because they are unable to initiate sprouting of the central retinal artery, which normally occurs in a VEGF-rich environment. This defect was not rescued by Ang1, suggesting that postnatal angiogenesis is a unique function of Ang2. Another surprising result of the gene knockout experiments was the observation that Ang2 Ϫ/Ϫ animals also show a defect in patterning of the dermal and intestinal lymphatic capillaries (Gale et al., 2002) . Specifically, the smooth muscle portions of the vessel walls fail to assemble properly. The phenotype of these animals resembles the consequences of heterozygous missense mutations that inactivate the VEGFR-3 tyrosine kinase (Karkkainen et al., 2000) . In keeping with these findings, the receptor's ligand, VEGF-C, also plays a major role in lymphatic development (Jeltsch et al., 1997) . During trophoblast invasion of the uterine wall and associated vessels, the cells express many of the same molecules that regulate lymphatic development: VEGF-C, VEGFR-3 (Zhou et al., 2002) , and Ang2 (this report). These observations suggest that the highly specialized, cytotrophoblast-lined uterine vessels that carry blood to the placenta may in some ways resemble the lymphatic vasculature. This hypothesis could help explain the vessels' unusually dynamic behavior that allows for enormous expansion in size without the loss of compliance.
Maternal vessels are also exposed to cytotrophoblastderived PlGF, which can displace VEGF-A, bind to VEGFR-2, and initiate angiogenic signals (Park et al., 1994) . PlGF actions appear to be especially important in the pathological growth of blood vessels. In the absence of this ligand, ischemia-and tumor-induced angiogenesis are downregulated without untoward effects on the normal physiological counterparts of these processes (Carmeliet et al., 2001) . Recently, investigators exploited the molecule's relatively limited spectrum of actions to show that PlGF induces, with efficiency comparable to that of VEGF, revascularization of ischemic myocardium and limbs without affecting healthy tissues (Luttun et al., 2002) . Of particular relevance to our studies is the fact that this ligand stimulated "arteriogenesis"-the formation of mature, durable, and functional arteries that did not regress once the angiogenic stimulus was removed. PlGF's actions on multiple targets, including endothelial and smooth muscle cells, as well as the recruitment of inflammatory cells, likely explain this effect. The same properties that make PlGF an interesting candidate for therapeutic angiogenesis also make this ligand an ideal component of the unusual strategy that cytotrophoblasts use to remodel maternal vessels, particularly arteries. In this regard, it is evident that the cells largely avoid secretion of ligands that play an important role in conventional angiogenic processes.
It is tempting to speculate that pregnancy conditions that are associated with faulty endovascular invasion could be the downstream consequences of cytotrophoblast misexpression of PlGF, VEGF-C, and/or Ang2. Preeclampsia, one of the leading causes of maternal mortality in the Western world, also increases perinatal mortality fivefold (Walker, 2000) . The clinical diagnostic criteria for this syndrome include the new onset of hypertension and the appearance of proteinuria and edema during pregnancy (Roberts et al., 1989) . Preeclampsia and about half the cases of intrauterine growth restriction are associated with particular placental pathologies. The extent of interstitial invasion by cytotrophoblasts is variable but frequently shallow, and endovascular invasion is consistently rudimentary (Brosens et al., 1972; Zhou et al., 1997b) . These anatomical defects suggested to us that, in preeclampsia, cytotrophoblast differentiation along the invasive pathway is abnormal. Biopsy specimens from the uterine wall of women with this syndrome showed that invasive cytotrophoblasts retain expression of adhesion receptors characteristic of the precursor pool of cytotrophoblasts and fail to turn on receptors that promote invasion and/or assumption of an endothelial phenotype (Zhou et al., 1997a) . The chain of events that initiate faulty cytotrophoblast differentiation is not known, but an imbalance in the factors that coordinate cytotrophoblast differentiation/invasion with remodeling of the uterine arteries, including PlGF, VEGF-C, and Ang2, could be involved. For example, in preeclampsia, cytotrophoblasts within the uterine wall undergo massive apoptosis (programmed cell death); this could be related to the actions of Ang2 in the absence of VEGF-A, a scenario that leads to programmed cell death . In support of this theory, we recently reported that cytotrophoblast expression of VEGF-A is downregulated in severe preeclampsia as compared with uncomplicated pregnancies (Zhou et al., 2002) . Experiments to determine whether Ang2 continues to be expressed in preeclampsia are in progress. Given that overexpression of PlGF and VEGF-C causes increased vessel permeability (Odorisio et al., 2002; Saaristo et al., 2002) , and an excess of Ang2 leads to blood vessel disruption (Maisonpierre et al., 1997) , it is possible that an overabundance of these factors could also be detrimental.
Finally, work from our laboratory and from other investigators (e.g., Charnock-Jones, 2002; Matsumoto et al., 2002) allows us to suggest a model that integrates what we have learned thus far about the molecular basis of cytotrophoblast invasion of the uterus eventually leading to occupation of the uterine vessels. We know that oxygen tension, hypoxia in particular, is a critical factor in stimulating cytotrophoblast proliferation and self-renewal. The von Hippel-Lindau tumor suppressor protein (pVHL), which cytotrophoblasts upregulate under conditions of low oxygen tension (Genbacev et al., 2001) , protects them from the normal spectrum of hypoxia-induced responses, including cell cycle exit. As the cells migrate into the uterus, they encounter a positive oxygen tension gradient that triggers pVHL degradation and the stabilization of hypoxia-inducible factor 2 alpha. This transcription factor positively regulates the production of vasculogenic/angiogenic factors that, in other cells, include VEGF-A (Enholm et al., 1997) , PlGF (Green et al., 2001) , and Ang2 (Mandriota and Pepper, 1998) . These data suggest that a similar effect may occur in cytotrophoblasts. In contrast, VEGF-C expression appears to be stimulated by growth factors and cytokines (Ristimaki et al., 1998) . The actions of soluble factors are consistent with evidence suggesting that maternal arterioles undergo structural changes before directly interacting with cytotrophoblasts (Craven et al., 1998) . We suspect that these factors directly or indirectly affect the expression of the downstream regulators, including adhesion molecules (Damsky and Fisher, 1998 ) and MMP-9 (Librach et al., 1991) , that carry out uterine invasion and vascular remodeling. Whether or not elements of this strategy could be exploited for therapeutic angiogenesis of ischemic conditions is an interesting question that has yet to be addressed.
